Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019

As the coronavirus disease 2019 (COVID-19, also called severe acute respiratory syndrome coronavirus-2) outbreak accelerates, vigorous and diverse efforts were made in developing treatment strategies. In addition to direct acting agents, increasing evidence showed some potential adjuvant therapies w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kuan-Hsuan, Wang, Sheng-Fan, Wang, Szu-Yu, Yang, Yi-Ping, Wang, Mong-Lien, Chiou, Sih-Hwa, Chang, Yuh-Lih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434021/
https://www.ncbi.nlm.nih.gov/pubmed/32568969
http://dx.doi.org/10.1097/JCMA.0000000000000375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434021/
https://www.ncbi.nlm.nih.gov/pubmed/32568969
http://dx.doi.org/10.1097/JCMA.0000000000000375

Ejemplares similares